Movement Alert｜ImmunityBio, Inc. Falls 5.03% in Regular Trading, trading at 8.325 USD

Market Focus10-22

On October 22, ImmunityBio, Inc. fell 5.03% in Regular Trading, trading at 8.325 USD/share, with Turnover of 49.1341 million USD.

Within the Biotechnology sector where ImmunityBio, Inc. belongs, peers showed mixed moves. Moderna, Inc. rose 2.36%, AbbVie fell 2.22%, Gilead Sciences fell 2.41%, Roivant Sciences Ltd. rose 4.24%, and Vertex Pharmaceuticals rose 0.17%.

The stock had also shown elevated volatility in recent sessions, including a 5.23% intraday rise on October 21 and a 5.45% intraday fall on October 19, while no fresh company-specific catalyst was identified in the available information for the latest move.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment